Featured News

We need YOUR help to achieve our mission of accelerating diagnosis, treatments, and a cure for celiac disease! Creating a Facebook fundraising page is a quick and easy way to raise funds and awareness.

The Foundation signs comment letter to CMS on proposed rule: Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses.

Increased consumption of a bacterial enzyme that is a common additive in processed foods might be related to the increased incidence of celiac disease.

The Celiac Disease Foundation Young Investigator Research Grant Award is a one- to three-year grant totaling up to $180,000. The purpose of the Award is to encourage exceptional investigators to pursue independent careers in celiac disease research.

Thank you for continuing to help us fight to protect coverage for the millions of Americans with celiac disease.

If you're interested in advancing treatments for cross-contact, and you meet the qualifications below, you may be able to participate in a study located in Seattle, Washington and Dallas, Texas.

ImmusanT, Inc., has announced that its therapeutic vaccine candidate, Nexvax2, has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA).

An estimated 3 million Americans have celiac disease, yet 2 million are undiagnosed. What will YOU do to help? Join us in the fight for a cure by making a…

Laura Boone, 29, development manager for the Celiac Disease Foundation, was a senior in college when she was first diagnosed with celiac disease. No one could determine why she was feeling so sick.

Celiac Disease Foundation quoted in Healthline article covering the Nexvax2 therapeutic vaccine candidate.